New pill shows promise for keeping people with narcolepsy awake longer
NCT ID NCT06767683
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing the long-term safety and how well ALKS 2680 works over time in people with narcolepsy type 1, type 2, or idiopathic hypersomnia. Participants take a once-daily tablet at different doses. The goal is to see if the drug remains safe and effective for staying awake during the day.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ALKS 2680 (a once-daily tablet)
What this could lead to
If successful, this could provide a long-term treatment option to help people with narcolepsy or idiopathic hypersomnia stay awake during the day.
What could go wrong
This is an extension study, so participants have already completed an earlier trial. It is still testing safety and durability, and side effects or lack of lasting benefit are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alkermes Investigational Site
RECRUITINGLittle Rock, Arkansas, 72211, United States
-
Alkermes Investigational Site
RECRUITINGLos Angeles, California, 90025, United States
-
Alkermes Investigational Site
RECRUITINGStanford, California, 94305, United States
-
Alkermes Investigational Site
RECRUITINGColorado Springs, Colorado, 80918, United States
-
Alkermes Investigational Site
RECRUITINGBrandon, Florida, 33511, United States
-
Alkermes Investigational Site
RECRUITINGMiami, Florida, 33176, United States
-
Alkermes Investigational Site
RECRUITINGWinter Park, Florida, 32789, United States
-
Alkermes Investigational Site
RECRUITINGAtlanta, Georgia, 30328, United States
-
Alkermes Investigational Site
RECRUITINGMacon, Georgia, 31210, United States
-
Alkermes Investigational Site
RECRUITINGStockbridge, Georgia, 30281, United States
-
Alkermes Investigational Site
RECRUITINGPeoria, Illinois, 61637, United States
-
Alkermes Investigational Site
RECRUITINGLansing, Michigan, 48911, United States
-
Alkermes Investigational Site
RECRUITINGSterling Heights, Michigan, 48314, United States
-
Alkermes Investigational Site
RECRUITINGLincoln, Nebraska, 68506, United States
-
Alkermes Investigational Site
RECRUITINGMiddletown, New Jersey, 07748, United States
-
Alkermes Investigational Site
RECRUITINGDenver, North Carolina, 28037, United States
-
Alkermes Investigational Site
RECRUITINGHuntersville, North Carolina, 28708, United States
-
Alkermes Investigational Site
RECRUITINGCanton, Ohio, 44718, United States
-
Alkermes Investigational Site
RECRUITINGCincinnati, Ohio, 45212, United States
-
Alkermes Investigational Site
RECRUITINGCincinnati, Ohio, 45245, United States
-
Alkermes Investigational Site
RECRUITINGDublin, Ohio, 43017, United States
-
Alkermes Investigational Site
RECRUITINGAbington, Pennsylvania, 19001, United States
-
Alkermes Investigational Site
RECRUITINGWyomissing, Pennsylvania, 19610, United States
-
Alkermes Investigational Site
RECRUITINGColumbia, South Carolina, 29201, United States
-
Alkermes Investigational Site
RECRUITINGAustin, Texas, 78731, United States
-
Alkermes Investigational Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
Alkermes Investigational Site
RECRUITINGSugar Land, Texas, 77478, United States
-
Alkermes Investigational Site
RECRUITINGMadison, Wisconsin, 53706, United States
-
Alkermes Investigational Site
RECRUITINGSydney, New South Wales, 2113, Australia
-
Alkermes Investigational Site
RECRUITINGBedford Park, South Australia, 5042, Australia
-
Alkermes Investigational Site
RECRUITINGClayton, Victoria, 3168, Australia
-
Alkermes Investigational Site
RECRUITINGBruges, Brugge, 8000, Belgium
-
Alkermes Investigational Site
RECRUITINGAlken, 3570, Belgium
-
Alkermes Investigational Site
RECRUITINGNamur, 5101, Belgium
-
Alkermes Investigational Site
RECRUITINGPrague, 128 21, Czechia
-
Alkermes Investigational Site
RECRUITINGMontpellier, Herault, 34295, France
-
Alkermes Investigational Site
RECRUITINGBordeaux, 33000, France
-
Alkermes Investigational Site
RECRUITINGBologna, 40139, Italy
-
Alkermes Investigational Site
RECRUITINGMilan, 20127, Italy
-
Alkermes Investigational Site
RECRUITINGVerona, 37134, Italy
-
Alkermes Investigational Site
RECRUITINGZwolle, 8025, Netherlands
-
Alkermes Investigational Site
RECRUITINGMadrid, Madrid, 28036, Spain
-
Alkermes Investigational Site
RECRUITINGBarcelona, 08036, Spain
-
Alkermes Investigational Site
RECRUITINGMadrid, 28043, Spain
-
Alkermes Investigator Site
RECRUITINGPhoenix, Arizona, 85054, United States
-
Alkermes Investigator Site
RECRUITINGSan Francisco, California, 94158, United States